Genomic & Biopharma News

Enhancing the efficacy of anti-PD-L1 immunotherapy for cancer
For most people, there is no scarier diagnosis than that of cancer. While treatments including chemotherapy and radiotherapy have been used since the 1940s and late 1800s, respectively, immunotherapy has more recently emerged as a viable and successful approach to cancer treatment.
News Medical Life Sciences, 2020-09-18 23:21:00

Cory Gardner’s bill has as much to do with politics as preexisting conditions
Sen. Cory Gardner, a Republican running in a tight race for reelection in Colorado, says he wants to protect people with medical conditions.
News Medical Life Sciences, 2020-09-18 23:03:00

Harnessing the microbiome potential
Spring is underway in parts of the US, and while Florida by no means undergoes the dramatic reappearance of foliage or colorful clumps of daffodils and azaleas, the southern part of the sunshine state experiences its share of spring renewals.  For instance, recently a brood of Muscovy duck (Cairina moschata) hatchlings appeared near Ocean Ridge Biosciences' laboratory.
ORB Company Blog, 2017-03-31 21:41:45

Adaptations found in RNA secondary structure in genes of two proteins of SARS-CoV-2
To investigate mutations in coronaviruses, a new study by scientists at Duke University and published on the preprint server bioRxiv, used a computational methodology, adaptiPhy, which identifies extra nucleotide substitutions in certain parts of the viral genome compared to mutations that have no effect on the genome.
News Medical Life Sciences, 2020-09-18 22:38:35

Genetic variants of human ACE2 are differentially recognized by SARS-CoV-2
Scientists at the University of Wisconsin reveals that the genetic variants of human angiotensin 2 (ACE2) receptors can have altered recognition by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the coronavirus disease 2019 (COVID-19) pandemic. The study is currently available on the bioRxiv* preprint server.
News Medical Life Sciences, 2020-09-18 22:13:35

ESMO: Pfizer's Ibrance flop in early breast cancer shouldn't hurt metastatic sales, exec says
ESMO: Pfizer's Ibrance flop in early breast cancer shouldn't hurt metastatic sales, exec says chelfand Fri, 09/18/2020 - 17:36
Fierce Pharma, 2020-09-18 21:36:24

ORB Employees Participate in 2019 Martin Luther King Day Event
ORB employees get a rare break from the lab on January 21, 2019. A group of Ocean Ridge Biosciences employees stepped out of the lab on a beautiful South Florida winter day to take part in an event honoring Martin Luther King. We got our hands dirty planting some flowers and shrubs at a local park in Deerfield Beach.
ORB Company News, 2019-01-22 23:24:59

Frozen Fecal Knives Honored by 2020 Ig Nobel Prizes
Other recipients of the award for laugh-worthy achievements experimented with alligators on helium and vibrating worms.
The Scientist, 2020-09-18 19:03:07

ESMO: Pfizer, Merck KGaA's Bavencio comes up short against placebo in risky head and neck cancer trial
ESMO: Pfizer, Merck KGaA's Bavencio comes up short against placebo in risky head and neck cancer trial chelfand Fri, 09/18/2020 - 14:29
Fierce Pharma, 2020-09-18 18:29:36

Combination of two mosquito-borne viruses may be a trigger for stroke
A deadly combination of two mosquito-borne viruses may be a trigger for stroke, new research published in the The Lancet Neurology has found.
News Medical Life Sciences, 2020-09-18 17:10:57

Researchers identify new path to defeating chronic myelogenous leukemia
Researchers have identified a second path to defeating chronic myelogenous leukemia, which tends to affect older adults, even in the face of resistance to existing drugs.
News Medical Life Sciences, 2020-09-18 16:56:36